Strategic National Stockpile and material threats

Section 319F–2 of the Public Health Service Act (42 U.S.C. 247d–6b) is amended— (1) in subsection (a)— (A) in paragraph (2)— (i) in subparagraph (A), by inserting Such review shall include a description of how the Secretary manages and mitigates risks associated with gaps between current inventory levels and stockpiling goals, prioritizes such risks, and tracks progress toward mitigation of such risks. after the first sentence; and (ii) in subparagraph (B)(i), by amending subclause (IV) to read as follows: (IV) the emergency health security threat or threats such countermeasure procurement is intended to address, including— (aa) whether such procurement is consistent with meeting emergency health security needs associated with such threat or threats; and (bb) in the case of a countermeasure that addresses a biological agent, whether such agent has an increased likelihood to become resistant to, more resistant to, or evade, such countermeasure relative to other available medical countermeasures;; (B) in paragraph (3)— (i) in subparagraph (B), by striking are followed, regularly reviewed, and updated with respect to such stockpile and inserting with respect to such stockpile are followed, regularly reviewed, and updated to reflect best practices; (ii) in subparagraph (I), by inserting, through a standard operating procedure, after ensure; (iii) by redesignating subparagraphs (H) through (K) as subparagraphs (I) through (L), respectively; (iv) by inserting after subparagraph (G) the following: (H) utilize tools to enable the timely and accurate tracking of the contents of the stockpile throughout the deployment of such contents, including tracking of the location and geographic distribution and utilization of such contents;; (v) in subparagraph (K), as so redesignated, by striking; and at the end and inserting a semicolon; (vi) in subparagraph (L), as so redesignated, by striking the period and inserting; and; and (vii) by adding at the end the following: (M) communicate to relevant vendors regarding modifications, renewals, extensions, or terminations of contracts, or the intent to exercise options for such contracts, within 30 days, as practicable, of such determination, including through the development of a contract notification process.; (C) in paragraph (5)(B), in the matter preceding clause (i), by inserting, which may accompany the review required under paragraph (2), after Representatives a report; and (D) in paragraph (6)(A)— (i) by redesignating clauses (viii) through (x) as clauses (ix) through (xi), respectively; and (ii) by inserting after clause (vii) the following: (viii) with respect to any change in the Federal organizational management of the stockpile, an assessment and comparison of any differences in the processes and operations resulting from such change, including— (I) planning for potential countermeasure deployment, distribution, or dispensing capabilities; (II) organizational structure; (III) communication with relevant stakeholders related to procurement decisions; (IV) processes related to procurement, deployment, and use of stockpiled countermeasures; (V) communication and coordination with the Public Health Emergency Medical Countermeasures Enterprise and other related Federal entities; (VI) inventory management; and (VII) availability and use of resources for such activities;; and (2) in subsection (c)(2)(C), by striking promptly and inserting, not later than 60 days after each such determination,; (3) in subsection (f)(1), by striking $610,000,000 for each of fiscal years 2019 through 2021, and $750,000,000 for each of fiscal years 2022 and 2023 and inserting $1,100,000,000 for fiscal year 2025, and $1,210,000,000 for fiscal year 2026; and (4) in subsection (g)(1), by striking 2019 through 2028 and inserting 2025 through 2034.